Judith M. LaLonde

发表

A critical assessment of docking programs and scoring functions.

C. E. Peishoff, G. Warren, C. W. Andrews, 2006, Journal of medicinal chemistry.

Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors.

Alexander W. Sun, J. Sodroski, J. Mascola, 2012, Journal of medicinal chemistry.

Structure-Based Design, Synthesis and Validation of CD4-Mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist

Peter D. Kwong, Wayne A. Hendrickson, Joel R. Courter, 2014, Accounts of chemical research.

Design , synthesis and biological evaluation of small molecule inhibitors of CD 4-gp 120 binding based on virtual screening

Young Do Kwon, Peter D. Kwong, Joel R. Courter, 2011 .

Structure-Based Design and Synthesis of an HIV-1 Entry Inhibitor Exploiting X-Ray and Thermodynamic Characterization.

J. Sodroski, J. Mascola, Judith M. LaLonde, 2013, ACS medicinal chemistry letters.

A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption.

C. Bewley, Judith M. LaLonde, I. Chaiken, 2013, Biochemistry.

Fluctuation dynamics analysis of gp120 envelope protein reveals a topologically based communication network

I. Shrivastava, Judith M. LaLonde, 2010, Proteins.

Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120.

J. Sodroski, R. Wyatt, Judith M. LaLonde, 2008, Structure.

HIV‐1 ENV gp120 structural determinants for peptide triazole dual receptor site antagonism

J. Sodroski, Judith M. LaLonde, I. Chaiken, 2013, Proteins.

O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1.

Judith M. LaLonde, G. Prendergast, M. Winters, 2016, European journal of medicinal chemistry.

Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors

Xiayang Qiu, Paul Carter, Judith M. LaLonde, 2001, Protein science : a publication of the Protein Society.

Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

Judith M. LaLonde, G. Prendergast, J. DuHadaway, 2008, Journal of medicinal chemistry.

Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

Judith M. LaLonde, G. Prendergast, P. Carroll, 2008, Journal of medicinal chemistry.

Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

Judith M. LaLonde, G. Prendergast, P. Carroll, 2008, Journal of medicinal chemistry.

Validation Studies of the Site-Directed Docking Program LibDock

Martha S. Head, Shashidhar N. Rao, Amit Kulkarni, 2007, J. Chem. Inf. Model..

The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1

Judith M. LaLonde, A. Muller, W. Malachowski, 2013, International journal of tryptophan research : IJTR.

Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.

J. Sodroski, Judith M. LaLonde, W. Hendrickson, 2016, ACS medicinal chemistry letters.

Enhanced dynamics of HIV gp120 glycoprotein by small molecule binding.

I. Shrivastava, Judith M. LaLonde, 2011, Biochemistry.

The up‐and‐down β‐barrel proteins

Judith M. LaLonde, L. Banaszak, D. Bernlohr, 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

CD4-Mimetic Small Molecules Sensitize Human Immunodeficiency Virus to Vaccine-Elicited Antibodies

H. Liao, J. Sodroski, B. Haynes, 2014, Journal of Virology.

Small-Molecule CD 4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp 120

J. Sodroski, R. Wyatt, Judith M. LaLonde, 2018 .

Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry.

A. Debnath, J. Hoxie, J. Mascola, 2011, ACS chemical biology.

Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.

J. Sodroski, F. Krebs, Judith M. LaLonde, 2008, Journal of medicinal chemistry.

The Active Core in a Triazole Peptide Dual‐Site Antagonist of HIV‐1 gp120

Judith M. LaLonde, E. Freire, I. Chaiken, 2010, ChemMedChem.

Spontaneous rearrangement of the β20/β21 strands in simulations of unliganded HIV-1 glycoprotein, gp120.

I. Shrivastava, Judith M. LaLonde, K. Wendel, 2012, Biochemistry.

Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening.

Young Do Kwon, Joel R Courter, Peter D Kwong, 2011, Bioorganic & medicinal chemistry.

Judith M. LaLonde, E. Freire, Amos B. Smith, 2011, Chemical biology & drug design.

Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site

A. Debnath, Judith M. LaLonde, P. Kwong, 2014, PloS one.

CD4-Mimetic Small Molecules Sensitize Human Immunodeficiency Virus to Vaccine-Elicited Antibodies

J. Sodroski, B. Haynes, R. Wyatt, 2014, Journal of Virology.